IntroductionMultiple Myeloma (MM). a prevalent hematological malignancy. poses significant treatment challenges due to varied patient responses and toxicities to chemotherapy. This study investigates the predictive value of pretreatment serum levels of interleukin-6 (IL-6). https://www.jmannino.com/best-buy-AniFlex-Complete-great-choice/